PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-42.17%
Negative net income growth while CSIQ stands at 1047.95%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
28.15%
D&A growth of 28.15% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
2977.78%
Deferred tax of 2977.78% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
49.84%
Working capital change of 49.84% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
-2866.31%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
132.79%
Growth of 132.79% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-316.68%
Both negative yoy, with CSIQ at -16416.53%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
250.43%
CFO growth of 250.43% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
47.12%
CapEx growth of 47.12% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
No Data
No Data available this quarter, please select a different quarter.
-360.19%
Negative yoy purchasing while CSIQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-32.16%
We reduce yoy other investing while CSIQ is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-21.16%
We reduce yoy invests while CSIQ stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-100.00%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-102.23%
Negative yoy issuance while CSIQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.